| scholarly article | Q13442814 |
| P50 | author | Diane P. Hanger | Q40398297 |
| Wendy Noble | Q42407218 | ||
| Anna Kinsey | Q57687442 | ||
| Claire Garwood | Q81460121 | ||
| P2093 | author name string | John Stephenson | |
| Brian H Anderton | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| minocycline | Q415336 | ||
| P304 | page(s) | 739-750 | |
| P577 | publication date | 2008-11-11 | |
| P1433 | published in | FASEB Journal | Q520194 |
| P1476 | title | Minocycline reduces the development of abnormal tau species in models of Alzheimer's disease | |
| P478 | volume | 23 |
| Q57927766 | A Closer Look into the Role of Protein Tau in the Identification of Promising Therapeutic Targets for Alzheimer's Disease |
| Q38073138 | A review: treatment of Alzheimer's disease discovered in repurposed agents |
| Q39039980 | A state of delirium: Deciphering the effect of inflammation on tau pathology in Alzheimer's disease. |
| Q34071942 | Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases |
| Q33349401 | Alzheimer's disease: clinical trials and drug development |
| Q37733587 | An overview of investigational antiapoptotic drugs with potential application for the treatment of neurodegenerative disorders |
| Q41854166 | Anti-inflammatory impact of minocycline in a mouse model of tauopathy. |
| Q48532877 | Astrocytes and neuroinflammation in Alzheimer's disease. |
| Q35202286 | Astrocytes are important mediators of Aβ-induced neurotoxicity and tau phosphorylation in primary culture. |
| Q24630229 | Attenuation of oxidative stress, inflammation and apoptosis by minocycline prevents retrovirus-induced neurodegeneration in mice |
| Q27342233 | Attenuation of pathogenic immune responses during infection with human and simian immunodeficiency virus (HIV/SIV) by the tetracycline derivative minocycline |
| Q35080456 | Calpain cleavage and inactivation of the sodium calcium exchanger-3 occur downstream of Aβ in Alzheimer's disease. |
| Q58008864 | Characterisation of tau in the human and rodent enteric nervous system under physiological conditions and in tauopathy |
| Q64057223 | Combinatory FK506 and Minocycline Treatment Alleviates Prion-Induced Neurodegenerative Events via Caspase-Mediated MAPK-NRF2 Pathway |
| Q40373414 | Early Minocycline and Late FK506 Treatment Improves Survival and Alleviates Neuroinflammation, Neurodegeneration, and Behavioral Deficits in Prion-Infected Hamsters |
| Q35852601 | Early treatment of minocycline alleviates white matter and cognitive impairments after chronic cerebral hypoperfusion |
| Q64237552 | Effects of Thioflavin T and GSK-3 Inhibition on Lifespan and Motility in a Model of Tauopathy |
| Q38974848 | Epigallocatechin-3-gallate and tetracycline differently affect ataxin-3 fibrillogenesis and reduce toxicity in spinocerebellar ataxia type 3 model. |
| Q89497605 | Exposure to 3-Nitropropionic Acid Mitochondrial Toxin Induces Tau Pathology in Tangle-Mouse Model and in Wild Type-Mice |
| Q90230828 | Formulated Chinese Medicine Shaoyao Gancao Tang Reduces Tau Aggregation and Exerts Neuroprotection through Anti-Oxidation and Anti-Inflammation |
| Q37527799 | Humulus japonicus inhibits the progression of Alzheimer's disease in a APP/PS1 transgenic mouse model |
| Q40757303 | IFN-γ promotes τ phosphorylation without affecting mature tangles |
| Q39431937 | Implications of peptide assemblies in amyloid diseases |
| Q58700943 | Inflammation: the link between comorbidities, genetics, and Alzheimer's disease |
| Q42119629 | Inhibition of Aβ42 oligomerization in yeast by a PICALM ortholog and certain FDA approved drugs |
| Q48513598 | Inhibition of microglial activation protects hippocampal neurogenesis and improves cognitive deficits in a transgenic mouse model for Alzheimer's disease |
| Q91660737 | Intersection of pathological tau and microglia at the synapse |
| Q38664605 | Intracellular and extracellular microtubule associated protein tau as a therapeutic target in Alzheimer disease and other tauopathies. |
| Q37630546 | Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease |
| Q34073334 | Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction. |
| Q37490746 | Minocycline as a potential therapeutic agent in neurodegenerative disorders characterised by protein misfolding |
| Q43156737 | Minocycline protects dopaminergic neurons against long-term rotenone toxicity. |
| Q35635783 | Minocycline reduces neuroinflammation but does not ameliorate neuron loss in a mouse model of neurodegeneration |
| Q38184606 | Modulation of inflammation in transgenic models of Alzheimer's disease |
| Q36617889 | Natural products as a rich source of tau-targeting drugs for Alzheimer's disease |
| Q37029561 | Natural products as a source of Alzheimer's drug leads |
| Q38759509 | Neuroinflammation in Synucleinopathies |
| Q92761855 | Neuroprotective Approach of Anti-Cancer Microtubule Stabilizers Against Tauopathy Associated Dementia: Current Status of Clinical and Preclinical Findings |
| Q38974344 | Non-Steroidal Anti-Inflammatory Drugs in Alzheimer's Disease and Parkinson's Disease: Reconsidering the Role of Neuroinflammation. |
| Q34869830 | PDE-4 inhibition rescues aberrant synaptic plasticity in Drosophila and mouse models of fragile X syndrome |
| Q40019330 | Poly(ADP-ribose)polymerase-1 modulates microglial responses to amyloid β. |
| Q26738336 | Prothrombin Kringle-2: A Potential Inflammatory Pathogen in the Parkinsonian Dopaminergic System |
| Q55062020 | Radiation-induced overexpression of transthyretin inhibits retinol-mediated hippocampal neurogenesis. |
| Q34179654 | Regulation of Tau Pathology by the Microglial Fractalkine Receptor |
| Q26865637 | Role of apoptosis in disease |
| Q33559303 | Roles of tau protein in health and disease |
| Q33650170 | Side effects of minocycline treatment in patients with fragile X syndrome and exploration of outcome measures |
| Q95324959 | Synergistic depletion of gut microbial consortia, but not individual antibiotics, reduces amyloidosis in APPPS1-21 Alzheimer's transgenic mice |
| Q52315334 | Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies? |
| Q90552914 | The Involvement of NLRP3 on the Effects of Minocycline in an AD-Like Pathology Induced by β-Amyloid Oligomers Administered to Mice |
| Q39149587 | The Role of Microglia in the Etiology and Evolution of Chronic Traumatic Encephalopathy. |
| Q64056267 | The therapeutic role of minocycline in Parkinson's disease |
| Q42060830 | Transcriptome analysis of a tau overexpression model in rats implicates an early pro-inflammatory response |
| Q37979824 | Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions |
| Q59329148 | Translation attenuation by minocycline enhances longevity and proteostasis in old post-stress-responsive organisms |
| Q26824702 | Tumor necrosis factor-induced cerebral insulin resistance in Alzheimer's disease links numerous treatment rationales |
| Q92258873 | β-Amyrin Ameliorates Alzheimer's Disease-Like Aberrant Synaptic Plasticity in the Mouse Hippocampus |
Search more.